UNSPSC 51142600: Stimulants and anorexiants

This classification denotes agents that suppress appetite.

UNSPSC 51142600 Stimulants and anorexiants is a Class code that in recent state and local procurement activity covers the supply of pharmaceuticals and medical products for public health initiatives, community health programs, and state pharmacy benefit systems. State and local governments are soliciting naloxone, generic pharmaceuticals, over-the-counter products, and related drug management systems through this code. Issuing bodies include county health departments (Seminole County, Florida), state health and human services agencies (Texas Health and Human Services Commission), and cooperative purchasing alliances serving multiple state and local jurisdictions (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). The mix spans single-jurisdiction county procurements and multi-state cooperative vehicles designed to standardize pharmaceutical sourcing across participating member agencies.

Recent activity centers on Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking annual supply of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to Sanford, with a response deadline of July 26, 2023 (note: deadline date appears inconsistent with posting date). The Texas Health and Human Services Commission released RFI HHS0017013 on April 3, 2026, to gather vendor capabilities on direct-to-manufacturer pharmacy initiatives outside traditional pharmacy benefit manager channels, as an exploratory phase preceding a formal RFP. MMCAP, administered by the Minnesota Department of Administration's Office of State Procurement and including Oregon participation, issued RFP S1070000015802 on January 20, 2026, for generic multi-source pharmaceuticals and OTC products to be distributed through three authorized wholesalers, with proposals due March 26, 2026, and evaluated on fixed pricing (10 percent), administrative compliance (5 percent), EDI capability (5 percent), fee agreement (5 percent), and price competitiveness (75 percent). All vendors must certify cGMP compliance, DSCSA adherence, maintain relationships with at least two of three designated wholesalers, and carry insurance including $5 million commercial general liability.